Histamine is a neurotransmitter and chemical mediator in multiple physiological processes. Histamine H 3 receptor is expressed in the nervous system, heart, and gastrointestinal tract; however, little is known about H 3 receptor in skeletal muscle. The aim of this study was to investigate the role of H 3 receptor in skeletal myotubes. The expression of H 3 receptor and myosin heavy chain (MHC), a late myogenesis marker, was assessed by real-time PCR and immunostaining in C2C12 skeletal myogenesis and adult mid-urethral skeletal muscle tissues. H 3 receptor mRNA showed a significant increase upon differentiation of C2C12 into myotubes: 1-, 26-, 91-, and 182-fold at days 0, 2, 4, and 6, respectively. H 3 receptor immunostaining in differentiated C2C12 cells and adult skeletal muscles was positive and correlated with that of MHC. The functional role of H 3 receptor in differentiated myotubes was assessed using an H 3 receptor agonist, (R)-a-methylhistamine ((R)-α-MeHA). Ca 2 þ imaging, stimulated by electric pacing, was decreased by 55% after the treatment of mature C2C12 myotubes with 1 μM (R)-α-MeHA for 10 min and 20 min, while treatment with 100 nm (R)-α-MeHA for 5 min caused 45% inhibition. These results suggested that H 3 receptor may participate in the maintenance of the relaxed state and prevention of over-contraction in mature differentiated myotubes. The elucidation of the role of H 3 R in skeletal myogenesis and adult skeletal muscle may open a new direction in the treatment of skeletal muscle disorders, such as muscle weakness, atrophy, and myotonia in motion systems or peri-urethral skeletal muscle tissues.
Introduction
Histamine is a well-known biogenic cationic amine that is synthesized, stored, and released by professional histaminesynthesizing cells, such as mast cells, basophils, and enterochromaffin cells. These cells express histidine decarboxylase, which effectively converts L-histidine to histamine (Ichikawa et al., 2010) . Histamine plays an important role as an inflammatory mediator and neurotransmitter and exerts its effects by binding to G protein-coupled histamine receptors H 1 -H 4 receptor with different affinities. H 1 receptor (pK i for histamine 4.2) and H 2 receptor (pK i for histamine 4.3) have long been established as histamine receptors that are expressed in various tissues (Walter and Stark, 2012) , but in the last decades, H 3 receptor and H 4 receptor, which have a higher affinity for histamine (pK i 8.0 and 8.2, respectively), have been characterized mostly in non-professional histamineproducing cells, such as dendritic cells and lymphocytes (Szeberenyi et al., 2001 and Kubo and Nakano, 1999) . The data obtained using HR agonists and/or antagonists have suggested that H 4 receptor is mainly involved in immunity and is expressed in immune cells, while H 3 receptor has been reported to be expressed in the brain and presynaptic membranes of myoneural junctions (Zampeli and Tiligada, 2009 and Leurs et al., 2005) . H 3 receptor activation with a selective agonist in the cardiac sympathetic nerve endings reduced the rise in intracellular Ca 2 þ concentration in response to membrane depolarization, while a selective H 3 receptor antagonist inhibited this effect (Silver et al., 2002) . Some studies have also found functional H 3 receptor expressed in smooth muscle cells, such as bronchial smooth muscle cells (Cardell and Edvinsson, 1994) and bladder detrusor cells (Neuhaus et al., 2006) . However, there has been no information on H 3 receptor expression in skeletal muscle cells, myoblasts, or myotubes, and, consequently, on the role of H 3 receptor in skeletal myogenesis.
The presence and functional role of H 3 receptor in smooth muscle cells led us to hypothesize that H 3 receptor may also be expressed in skeletal muscles, where it may play a role in cytoplasm and calcium regulation of the myotubes.
Materials and methods

Cell culture
Mouse C2C12 myoblasts were obtained from the Turku Center for Biotechnology, University of Turku, Finland (Pallari et al., 2011) , and were maintained in Dulbecco's Modified Eagle's Medium (DMEM, Lonza/BioWhittaker, Walkersville, MD, USA) supplemented with 10% fetal bovine serum (FBS; HyClone, Boston, MA, USA), antibiotics, and L-glutamine, at 37 1C in a humidified 5% CO 2 atmosphere. The differentiation medium had the same composition, except that FBS was reduced to 1%. The cells were passaged at 80% confluence using trypsinization with 0.5% trypsin in 0.5 mM EDTA (Gibco BRL, Life Technologies, Gaithersburg, MD, USA). Three parallel samples were cultured concurrently.
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
To investigate the expression of H 3 receptor during C2C12 myogenesis, 5 Â 10 4 cells/well were seeded in 12-well plates (CellStar, Greiner Bio-One, Frickenhausen, Germany) in 10% FCScontaining DMEM for 2 days. After reaching 80% confluence, cell monolayers were switched to the differentiation medium to induce myogenesis. Total RNA was isolated from C2C12 cells at days 0, 2, 4, and 6 using the RNeasy Mini Kit (QIAGEN, Düsseldorf, Germany) according to the manufacturer's instructions, and 1 μg of total RNA was reverse-transcribed using the iScript cDNA Synthesis Kit (BioRad Laboratories, Hercules, CA, USA). qRT-PCR was performed with 100 ng first-strand cDNA as a template, using iQ SYBR Green Supermix (Bio-Rad) and an iCycler iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad 0 ; amplicon size 156 bp) were designed using the NCBI Primer BLAST program. The mRNA copy numbers in the samples were determined in triplicate and were normalized against that of PBGD. The results were analyzed using the comparative CT method and the expression levels of the cells of each individual were normalized to the expression of D0. IgG (Invitrogen, Carlsbad, CA, USA) diluted 1:400 in 0.1% BSA-PBS for 1 h, washed three times for 5 min in PBS each time, and counterstained with 4 0 , 6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, St. Louis, MO, USA) diluted 1:2000 in distilled water, for 5 min. The coverslips were washed quickly twice in PBS and distilled water for 10 min before mounting with Vectashield (Vector Laboratories Inc., Burlingame, CA, USA). Labeled slides were photographed using a Leica DM 6000 B/M fluorescence microscope equipped with a motorized Leica XY-stage and connected to a Leica DFC 420 digital camera (Leica Microsystems, Wetzlar, Germany) and analyzed using the Leica Application Suite Advanced Fluorescence 2.5.0.6735 software.
Immunohistochemistry
The study protocol was approved by the institutional Medical Ethics Committee and was in accord with the 1983 Declaration of Helsinki. Informed consent was obtained from all volunteers.
The mid-urethral striated muscle samples were obtained from three healthy male volunteers by biopsy. The samples were fixed in 40% formaldehyde solution for 24 h and embedded in paraffin. Paraffin blocks were sliced into 3-5-μm sections, which were placed on the slides and incubated at 37 1C overnight. Samples were deparaffinized by using xylene and antigens were retrieved by heating samples in a microwave in 10 mM citrate buffer, and were then incubated in 1% hydrogen peroxide to quench endogenous peroxidase activity. The samples were stained using a VECTASTAIN Elite ABC Kit (Rabbit IgG) (PK-6101, Vector Laboratories, Burlingame, CA, USA). The slides were blocked in 10% normal donkey serum for 1 h and incubated at 4 1C overnight with 1 μg/ml of primary antibodies, viz., polyclonal affinitypurified rabbit anti-human MHC IgG, rabbit anti-human H 3 receptor polyclonal antibodies, or non-immune rabbit IgG used as negative control. The slides were washed three times for 5 min in PBS and were then incubated with the secondary donkey antirabbit IgG diluted 1:400 in 0.1% BSA-PBS for 1 h. After washing three times for 5 min in PBS, the slides were incubated with the ABC complex for 1 h, washed three times for 5 min in PBS, and were then incubated in the peroxidase substrate solution until the desired staining intensity appeared (maximum time: 10 min). The slides were then washed in distilled water, counterstained in Mayer's hematoxylin, washed in running water, dehydrated in graded ethanol, and cleared in xylene before being mounted in Vectashield. Japan) at 50 frames/s. Data acquisition was controlled and the recordings were analyzed using HC Image software (Hamamatsu Photonics K.K., Hamamatsu, Japan). The cells for analysis were manually selected in the regions of interest and the background was subtracted before quantifying the fluorescence relative to baseline fluorescence (F/F 0 ).
Statistical analysis
All values are given as mean 7 standard error of the mean (S.E.M.). Statistical differences were evaluated using the MannWhitney test (Matlab, MathWorks Inc., Natick, MA, USA).
Results
C2C12 cell morphology during myogenesis
Before differentiation, C2C12 cells presented as mononuclear myoblasts around 10-μm in diameter, round or spindle-like; they were well spread and showed many contacts with the substrate (Fig. 1A) . When the cells were induced to differentiate, they started proliferating and migrating and then arranged themselves along a single direction to fuse into myotubes. After 6 days of differentiation, the cells fused into long, multinucleated myotubes of over 150-μm in diameter (Fig. 1B ).
H 3 receptor expression during myogenesis and in human midurethral striated muscles
The expression of H 3 receptor and the late myogenesis marker MHC during C2C12 differentiation was assessed using qRT-PCR. MHC increased over the course of differentiation by 7168-, 89487- and 279897-fold at days 2, 4, and 6, respectively, compared to day 0 (Fig. 1D) . The expression of H 3 receptor, which was initially low in C2C12 myoblasts, also strongly increased with differentiation when compared to day 0; by 26-, 91-, and 182-fold at days 2, 4, and 6, respectively (Fig. 1C) .
The immunofluorescence staining of the MHC protein was negative before differentiation (Fig. 2) , but was strongly positive at day 6 (Fig. 2) . Similarly, immunostaining for the H 3 receptor protein was negative at day 0 (Fig. 2) , but was strongly positive at day 6 (Fig. 2) .
Human mid-urethral striated muscles showed positive immunostaining for both MHC and H 3 receptor proteins in the filiformlike muscle cells (Fig. 2) . (Fig. 3) . The result of (R)-α-MeHA treatment at 30 min is not shown, because obvious decay of the Ca 2 þ -labeled
Fluo-4 was detected at this time.
Discussion
To our knowledge, this is the first investigation of the role of H 3 receptor in skeletal muscle cells. When we first observed H 3 receptor immunostaining in adult skeletal muscle, we hypothesized that H 3 receptor may play a role in skeletal myogenesis or mature skeletal muscle cells. To test this proposal, we assessed H 3 receptor expression kinetics during differentiation of mouse C2C12 myoblast cells. H 3 receptor expression was almost absent in Fig. 2 . Immunostaining of H 3 receptor and MHC in differentiated C2C12 cells and adult mid-urethral skeletal muscle tissues. C2C12 cells were grown in 10% FCS-containing DMEM; the medium was then switched to 1% FCS DMEM and differentiated for 6 days. C2C12 cells and mid-urethral skeletal muscle tissues were fixed in 40% formaldehyde solution and stained with the anti-H 3 receptor antibody, anti-MHC antibody, and non-immune rabbit IgG. Upper panel: C2C12 cells, differentiation day 0 (Day 0); middle panel: C2C12, differentiation day 6 (Day 6); lower panel: mid-urethral skeletal muscle tissues. C2C12 cells were counterstained with DAPI and mid-urethral skeletal muscle tissues were counterstained with Mayer's hematoxylin, to reveal cell nuclei (blue). The scale bar represents 50 mm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Fig. 3 . H 3 receptor agonist decreased cytoplasmic Ca 2 þ imaging during electrical stimulation in the skeletal myotubes. C2C12 myotubes, differentiated for 7 days, were loaded with Fluo-4 AM Ca 2 þ indicator dye and were then incubated with the H 3 receptor agonist (R)-α-MeHA at different concentrations (1 nM, 10 nM, 100 nM, 1 μM, 10 μM, 100 μM) and blank control (Elliot medium) for 5, 10, and 20 min before electric pacing. Ca 2 þ imaging was performed as described in Section 2. The data are expressed as the mean 7 standard deviation (S.E.M.), the number of independent experiments is 3, and P o0.01 compared to control is indicated; typically this is indicated with a * .It is Po 0.05 compared to 5 min results; typically this is indicated with a ♯.
myoblasts, but increased markedly with myogenesis, suggesting that H 3 receptor mostly functions in differentiated myoblasts that were fused into myotubes. H 3 receptor functional analysis, using an H 3 receptor agonist (R)-α-MeHA, revealed that in fully differentiated 7-day myotubes, H 3 receptor activation decreased Ca 2 þ imaging evoked by electrical stimulation. The lowest (R)-α-MeHA concentration used (1 nM) was below the agonist affinity for H 3 receptor (pK i ¼ 8.4) in the brain (Chen et al., 2003 and Li et al., 2014) and had no effect on the cytoplasmic Ca 2 þ imaging under electrical stimulation in our study. On the other hand, the highest (R)-α-MeHA concentration used (100 μM) was also less active, probably because of combinatorial effects, due to nonspecific activation of other receptors (H 1 receptor or H 2 receptor) on the cell membrane (Chen et al., 2015) , which counteracted the response (Leurs et al., 1998) , or probably as a self-protective mechanism. The highest inhibitory effect of 1 μM (R)-α-MeHA, exerted after 10-min or 20 min treatment, was in agreement with a previous pharmacological study on histamine receptor ligands, where (R)-α-MeHA also showed the highest efficacy at 1 μM (Kottke et al., 2011 leading to a decrease in intracellular Ca 2 þ levels involving the impaired entrance of Ca 2 þ through voltage-gated ion channels (Leurs et al., 2005) . In cardiac sympathetic nerves, H 3 receptormediated inhibition of norepinephrine exocytosis was caused by H 3 receptor-G i /G o coupling, and inhibition of adenylyl cyclase activity and cAMP formation, leading to diminished protein kinase A (PKA) activity, and decreased Ca 2 þ influx through voltageoperated Ca 2 þ channels (Leurs et al., 2005 ). In our experiments, H 3 receptor activation in the differentiated C2C12 myotubes decreased intracellular Ca 2 þ imaging in response to electrical pacing, which is similar to the effect observed in cardiac sympathetic nerve endings. In mature skeletal muscle cells, the major source of Ca 2 þ is the intracellular Ca 2 þ store in the sarcoplasmic reticulum (SR), which accumulates Ca 2 þ from the cytoplasm in an ATP-dependent manner by the action of Ca 2 þ -ATPase (Endo, 2009 ). Most of this calcium moves back and forth across the SR membrane in cycles of contraction and relaxation. The channel responsible for release from the SR is the ryanodine receptor (RyR). The RyR that mediates the efflux of Ca 2 þ from the SR has a central role in excitationcontraction coupling between sarcolemmal depolarization and SR Ca 2 þ release (Stokes and Wagenknecht, 2000) .
In early studies of isolated frog skeletal muscles, catecholamines induced sarcolemmal-depolarized contraction through elevation of cAMP, which also stimulates RyR on the SR, and increased Ca 2 þ flux out from the SR into the cytoplasm (Gonzalez-Serratos et al., 1981) . Regulation of Ca 2 þ concentration in the cytoplasm is important in coupling excitation and contraction in skeletal muscle (Emrick et al., 2010) . Evidence has suggested that the level of cyclic AMP may be involved in the increase of Ca 2 þ in the cytoplasm (Ong and Steiner, 1977 and Lanner et al., 2010) and is associated with contraction of both cardiac and skeletal muscles (Gonzalez-Serratos et al., 1981) . In cultured skeletal myotubes, the activated calcitonin gene-related peptide (CGRP) receptor can positively couple to Gs proteins and activation of adenylate cyclase, increasing levels of cAMP generation and subsequent protein kinase A (PKA) activation to increase contraction force. During this process, CGRP increases voltage-gated SR Ca 2 þ release within hours, resulting from a quantitatively similar increase in releasable SR Ca 2 þ content (Avila et al., 2007) . When chicken and rat skeletal muscle cells were cultured for 7 days and were then subjected to electrical stimulation for additional 2 days, the ability of these cells to synthesize cAMP was increased by almost two-fold (Young et al., 2000) . In our study, electrical stimulation of differentiated C2C12 myotubes may have caused upregulation of cAMP biosynthesis; in this case, H 3 receptor activation may inhibit cAMP elevation and prevent overcontraction. Other studies found histidine decarboxylase activity was very low in normal non exercised muscle (Endo et al., 1998 ) and mice treated with a H 3 receptor antagonist display no significant effects on prolonged walking endurance (NiijimaYaoita et al., 2012) , suggesting that histamine and H 3 receptor signaling have a limited role on normal muscle physiology. It is the possibility that H 3 receptor is activated only in exercised and/or excited muscle. In addition, we also tried ciproxifan (histamine H 3 -receptor antagonist, pK i ¼ 9.1-9.4) 1 μM instead of (R)-α-MeHA to do the experiment, and found there was no cytoplamic Ca 2 þ imaging arise compare to the control. So H 3 receptor blockage might not enhance cell contraction.
In conclusion, we found that the histamine H 3 receptor agonist (R)-α-MeHA can attenuate cytoplasmic Ca 2 þ imaging during electrical stimulation in differentiated C2C12 myotubes, which may facilitate relaxation of cells and prevent over-contraction in electrically stimulated C2C12 myotubes. Attenuation of the cytoplasmic Ca 2 þ imaging may occur via activation of H 3 receptor to induce inhibition of cAMP formation, or activation of PLA 2 , release of arachidonic acid, and the subsequent decrease in intracellular Ca 2 þ levels. These effects are most prominent early during myotube maturation. Whether these effects also occur in muscle regeneration remains to be elucidated.
